VIE/IPN (VIE/IPN)

Vienna Stock Exchange: VIE/IPN · EUR

€155

+2.60 (+1.7%)· Recorded snapshot

Market cap	12.5B
Revenue (ttm)	4.3B
Net income (ttm)	512.6M
EPS (ttm)	€6.17
P/E (trailing)	25.0x
P/E (forward)	10.0x
Dividend	€1.60 (1.04%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.3B
Net income (ttm): 512.6M
EPS (ttm): €6.17
P/E (trailing): 25.0x
P/E (forward): 10.0x
Market cap: 12.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E10

P25 n/aP50 n/aP75 n/a

Trailing P/E25

P25 n/aP50 n/aP75 n/a

ROE11.4

P25 n/aP50 n/aP75 n/a

ROIC23.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/IPN indicators

Market & fundamental data

Available fields

246

Groups with data

Currency

EUR

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	France
Country code	AT
Earnings date	2027-02-11
Employees	5,535
Employees change	177
Employees growth	3.3%
Enterprise value	EUR 11.5B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1929
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	FR0010259150
Last earnings date	2026-07-30
Last refreshed	2026-10-29
Market cap	EUR 12.5B
Next earnings date	2027-02-11
Price	EUR 154.50
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/IPN
Website	https://www.ipsen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.1x
Average P/E ratio (3Y)	20.15x
Average P/E ratio (5Y)	16.6x
Earnings yield	3.99%
EV/Earnings	22.49x
EV/EBIT	9.81x
EV/EBITDA	7.58x
EV/FCF	9.4x
EV/Sales	2.69x
FCF / EV yield	10.64%
FCF yield	9.79%
Forward P/E	10.03x
Graham number	90.84522
Graham upside	-41.2%
Lynch fair value	EUR 31.59
Lynch upside	-79.56%
P/(FCF - SBC) ratio	10.59x
P/(OCF - SBC) ratio	9.93x
P/B ratio	2.66x
P/E ratio	25.04x
P/FCF ratio	10.22x
P/OCF ratio	9.61x
P/S ratio	2.92x
Price / tangible book value	6.45x
Price/EBITDA ratio	8.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	27.38%
EBITDA margin	34.81%
Effective tax rate	27%
FCF margin	28.59%
Gross margin	81.01%
Operating margin	27.38%
Pretax margin	16.33%
Profit margin	11.95%
Profit per employee	EUR 92,611
Profitable quarters	13
Profitable years	6
Revenue per employee	EUR 775,303
ROA	10.28%
ROA (5Y)	9.79%
ROCE	20.52%
ROE	11.44%
ROE (5Y)	16.41%
ROIC	23.16%
ROIC (5Y)	22.31%
SBC / revenue	1%
Tax / revenue	4.41%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	14.85%
EPS growth (Q)	21.5%
EPS growth (QoQ)	269.3%
EPS growth 10Y	10.39%
EPS growth 3Y	-7.55%
EPS growth 5Y	-1.25%
EPS growth quarters	1
EPS growth years	1
FCF growth	51.93%
FCF growth (Q)	41.01%
FCF growth (QoQ)	18.3%
FCF growth 3Y	11.93%
FCF growth 5Y	12.15%
Gross profit growth	15.83%
Gross profit growth (Q)	19.02%
Gross profit growth 3Y	9.76%
Gross profit growth 5Y	9.63%
Net income growth	14.45%
Net income growth (Q)	20.69%
Net income growth (QoQ)	268.13%
Net income growth 3Y	-7.54%
Net income growth 5Y	-1.33%
Net income growth quarters	1
Net income growth years	1
OCF growth	33.66%
OCF growth (Q)	31.59%
OCF growth (QoQ)	13.31%
OCF growth 10Y	19.29%
OCF growth 3Y	10.34%
OCF growth 5Y	11.09%
Operating income growth	14.55%
Operating income growth (Q)	29.19%
Operating income growth 3Y	7.58%
Operating income growth 5Y	9.13%
Revenue growth	14.14%
Revenue growth (Q)	18.69%
Revenue growth (QoQ)	15.42%
Revenue growth 10Y	10.94%
Revenue growth 3Y	10.78%
Revenue growth 5Y	9.82%
Revenue growth quarters	5
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -78.1M
Depreciation and amortization	EUR 318.7M
EBIT	EUR 1.2B
EBITDA	EUR 1.5B
EPS	EUR 6.17
Financing cash flow	EUR -227.7M
Free cash flow	EUR 1.2B
Free cash flow minus SBC	EUR 1.2B
Gross profit	EUR 3.5B
Income taxes	EUR 189.2M
Investing cash flow	EUR -557.5M
Net borrowing	EUR -13.9M
Net cash flow	EUR 519M
Net income	EUR 512.6M
Operating cash flow minus SBC	EUR 1.3B
Operating income	EUR 1.2B
Revenue	EUR 4.3B
Stock-based compensation	EUR 42.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.85
Book value per share	EUR 57.15
Debt / EBITDA	0.63
Debt / equity	0.2
Debt / FCF	0.79
Goodwill	EUR 650.4M
Interest coverage	28.45
Long-term assets	EUR 4.1B
Long-term liabilities	EUR 1B
Net cash (debt)	EUR 1B
Net cash / market cap	8.04%
Net cash growth	107.88%
Net debt / EBITDA	-0.68
Net debt / equity	-0.21
Net debt / FCF	-0.82
Piotroski F-Score	7
Property, plant and equipment	EUR 661.5M
Shareholders' equity	EUR 4.7B
Tangible book value	EUR 1.9B
Tangible book value per share	EUR 23.58
Total assets	EUR 7.5B
Total cash	EUR 2B
Total debt	EUR 963.1M
Total liabilities	EUR 2.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.6
Current assets	EUR 3.4B
Current liabilities	EUR 1.7B
Current ratio	1.97
Inventory turnover	3.58
Net working capital	EUR -37M
Quick ratio	1.77
Working capital	EUR 1.7B
Working capital turnover	2.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.38%
Dividend growth	14.29%
Dividend growth (3Y)	10.06%
Dividend growth (5Y)	9.86%
Dividend growth years	1
Dividend payment date	2026-06-05
Dividend payment years	7
Dividend payout frequency	Annual
Dividend per share	EUR 1.60
Dividend yield	1.04%
Ex-dividend date	2026-06-03
Last dividend	EUR 1.60
Payout ratio	25.71%
Shareholder yield	1.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 158.88
1D price change	1.71%
1M price change	7.59%
1M total return	7.59%
1W price change	3.69%
1W total return	3.69%
1Y price change	28.97%
1Y return CAGR	30.36%
1Y total return	30.34%
20-day SMA	EUR 146.41
200-day SMA	EUR 156.33
3M price change	-2.95%
3M total return	-2.95%
3Y price change	29.29%
3Y return CAGR	10.19%
3Y total return	33.8%
50-day SMA	EUR 153.85
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 173.10
52-week high date	2026-05-07
52-week low	EUR 116.40
52-week low date	2026-01-05
5Y price change	75.25%
5Y return CAGR	13.19%
5Y total return	85.76%
6M price change	-5.45%
6M total return	-4.44%
All-time high	EUR 173.10
All-time high date	2026-05-07
All-time low	EUR 66.65
All-time low date	2021-03-12
Average true range (ATR)	EUR 2.46
Average volume	3.5
Change from 52-week high	-10.75%
Change from 52-week low	32.73%
Change from all-time high	-10.75%
Change from all-time low	131.81%
Change from open	1.64%
Day's gap	0.07%
High price	EUR 154.50
Low price	EUR 152.00
Monthly RSI	58.38
Open price	EUR 152.00
Position in 52-week range	100%
Previous close	EUR 151.90
Price vs 150-day SMA	-2.76%
Price vs 20-day SMA	5.53%
Price vs 200-day SMA	-1.17%
Price vs 50-day SMA	0.42%
Relative volume	20
RSI	60.86
Sharpe ratio	0.9
Sharpe ratio (3Y)	0.36
Sharpe ratio (5Y)	0.57
Sortino ratio	1.49
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.99
Weekly RSI	50.67
YTD price change	29.07%
YTD total return	30.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29.8M
Shares change (QoQ)	-0.37%
Shares change (YoY)	-0.38%
Shares held by insiders	26.89%
Shares held by institutions	18.24%

Deeper analysis on VIE/IPN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/IPN report

Is a complete VIE/IPN research report available?

No complete published report is available for vie/IPN (VIE/IPN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/IPN (VIE/IPN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/IPN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/IPN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/IPN

Frequently asked questions